MARKET

SNN

SNN

Smith & Nephew
NYSE

Real-time Quotes | Nasdaq Last Sale

36.59
+0.07
+0.19%
After Hours: 36.59 0 0.00% 16:14 09/27 EDT
OPEN
36.55
PREV CLOSE
36.52
HIGH
36.78
LOW
36.35
VOLUME
325.07K
TURNOVER
--
52 WEEK HIGH
46.10
52 WEEK LOW
34.29
MARKET CAP
16.09B
P/E (TTM)
29.13
1D
5D
1M
3M
1Y
5Y
Here's Why You Should Retain Globus Medical (GMED) for Now
Zacks.com · 5d ago
Billionaire Ray Dalio’s Thoughts on Bitcoin and 10 New Stocks in Portfolio
In this article, we discuss the 10 new stocks in the portfolio of billionaire Ray Dalio. If you want to skip our detailed analysis of these stocks, go directly to Billionaire Ray Dalio’s 5 New Stock Picks. Billionaire Ray Dalio has been one of the most suc...
Insider Monkey · 09/20 13:23
4 Top Healthcare Stocks to Buy in September
StockNews.com · 09/14 14:25
Estimating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
How far off is Smith & Nephew plc ( LON:SN. ) from its intrinsic value? Using the most recent financial data, we'll...
Simply Wall St. · 09/09 13:53
Smith+Nephew (SNN) Releases New Features for Hip Arthroplasty
Zacks.com · 09/02 13:22
Smith+Nephew introduces pioneering new technologies for its JOURNEY™ II total knee arthroplasty portfolio
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of two significant new technologies to its total knee arthroplasty (TKA) portfolio - the JOURNEY II Medial Dished (MD) for TKA and SYNC Performance In...
PR Newswire · 09/01 13:00
Smith+Nephew to expand Real Intelligence digital ecosystem and CORI™ Surgical System with total hip arthroplasty
PR Newswire - PRF · 09/01 11:00
Smith+Nephew launches new total ankle and total shoulder replacement technologies; showcases recently acquired Extremity Orthopaedics portfolio at AAOS
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will feature its recently expanded Extremities portfolio at the American Academy of Orthopaedic Surgeons 2021 Annual Meeting being held in San Diego, CA. The exciti...
PR Newswire · 08/31 13:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SNN. Analyze the recent business situations of Smith & Nephew through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SNN stock price target is 50.33 with a high estimate of 55.00 and a low estimate of 47.00.
EPS
Institutional Holdings
Institutions: 366
Institutional Holdings: 44.82M
% Owned: 10.20%
Shares Outstanding: 439.62M
TypeInstitutionsShares
Increased
82
6.84M
New
27
2.15M
Decreased
72
12.53M
Sold Out
35
635.60K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.61%
Healthcare Equipment & Supplies
-1.89%
Key Executives
Non-Executive Chairman/Independent Director
Roberto Quarta
Chief Executive Officer/Executive Director
Roland Diggelmann
Chief Financial Officer/Executive Director
Anne-Francoise Nesmes
Corporate Executive
Brad Cannon
Corporate Executive
Peter Coenen
Corporate Executive
Myra Eskes
Corporate Executive
Simon Fraser
Corporate Executive
Mark Gladwell
Corporate Executive
Skip Kiil
Corporate Executive
Vasant Padmanabhan
Chief Human Resource Officer
Elga Lohler
Chief Compliance Officer
Catheryn O'Rourke
Other
Phil Cowdy
Other
Melissa Guerdan
Secretary
Susan Swabey
Non-Executive Independent Director
Erik Engstrom
Non-Executive Independent Director
Robin Freestone
Non-Executive Independent Director
John Ma
Non-Executive Independent Director
Katarzyna Mazur-Hofsaess
Non-Executive Independent Director
Rick Medlock
Non-Executive Independent Director
Marc Owen
Non-Executive Independent Director
Angie Risley
Non-Executive Independent Director
Bob White
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.278
09/30/2021
--
Dividend USD 0.452
04/05/2021
07/29/2020
Dividend USD 0.278
10/01/2020
--
Dividend USD 0.452
04/02/2020
--
Dividend USD 0.278
10/03/2019
--
Dividend USD 0.43
04/04/2019
--
Dividend USD 0.27
10/04/2018
02/08/2018
Dividend USD 0.444
04/05/2018
08/28/2017
Dividend USD 0.236
10/05/2017
02/27/2017
Dividend USD 0.37
03/29/2017
09/01/2016
Dividend USD 0.236
10/05/2016
02/08/2016
Dividend USD 0.37
04/20/2016
08/31/2015
Dividend USD 0.226
10/07/2015
04/17/2015
Dividend USD 0.372
04/15/2015
10/14/2014
Dividend USD 0.22
10/22/2014
02/19/2014
Dividend USD 0.83
04/17/2014
08/27/2013
Dividend USD 0.51
10/09/2013
03/08/2013
Dividend USD 0.79
04/17/2013
About SNN
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Webull offers kinds of Smith & Nephew plc (ADR) stock information, including NYSE:SNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNN stock methods without spending real money on the virtual paper trading platform.